GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

X T L Biopharmaceuticals XTLB.TA ยท ILA

Health Care ยท Tel Aviv ยท ๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

Compare

1.30

-7.14%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

X T L Biopharmaceuticals โ€” daily TASE:XTLB

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View X T L Biopharmaceuticals on TradingView โ†—
Market value
ILS 12.3m
Last close ร— shares
Volume
820k
Shares, 9 Nov 2026

About X T L Biopharmaceuticals

Its shares trade on Tel Aviv under the ticker XTLB.TA. It has been listed since 1 September 2000. In the fiscal year to 31 December 2024, it reported revenue of $451,000 and a net loss of $1.0m. At that date it held total assets of $8.6m and shareholders' equity of $5.4m.

XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company is headquartered in New York City, New York. The company went IPO on 2000-09-01. The firm is engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Companyโ€™s developed drug candidate is hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogrenโ€™s syndrome (SS). Its hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. Its rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM).

Figures and description from our data supplier, not checked against the company's own report.

More about X T L Biopharmaceuticals โ†’

Latest on X T L Biopharmaceuticals

Our reporting

We have not reported on X T L Biopharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

โ€”

Return

โ€”

Leaves out fees, taxes and financing.

Frequently asked questions

What is X T L Biopharmaceuticals's ticker?

X T L Biopharmaceuticals trades as XTLB.TA on Tel Aviv, under ISIN IL0010854979.

What was X T L Biopharmaceuticals's last closing price?

1.30 on 9 Nov 2026. The figure is in ILA and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.